Cargando…

The Road to Hell Is Paved with Good Intentions: Why Harm–Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research

SIMPLE SUMMARY: The European legislation on project evaluation of animal research has recently changed. Every procedure on live non-human vertebrates and cephalopods has to be approved in a project evaluation (harm–benefit analysis (HBA)) that weighs the inflicted harms on animals against potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm, Herwig, Eggel, Matthias, Deplazes-Zemp, Anna, Biller-Andorno, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615301/
https://www.ncbi.nlm.nih.gov/pubmed/28892015
http://dx.doi.org/10.3390/ani7090070
Descripción
Sumario:SIMPLE SUMMARY: The European legislation on project evaluation of animal research has recently changed. Every procedure on live non-human vertebrates and cephalopods has to be approved in a project evaluation (harm–benefit analysis (HBA)) that weighs the inflicted harms on animals against potential prospective benefits. Recent publications on the HBA prioritise “societal benefits” that have a foreseeable, positive impact on humans, animals, or the environment over gaining knowledge (e.g., basic research). However, we argue that whether potential prospective societal benefits are realized is (a) impossible to predict and (b) exceeds the scope and responsibility of researchers. Furthermore, the emphasis on practical benefits has the drawback of driving researchers into speculation on the practical benefit of their research and, therefore, into promising too much. Repeated failure to deliver proclaimed practical benefits will lead to a loss of trust and credibility in research. The concepts of benefit and benefit assessment in the HBA, as well as the HBA itself, require re-evaluation in a spirit that embraces the value of knowledge in our society. Research projects should be measured by the quality of the research they perform and by the contributions they make to a specific field of research or research program. Only then can promises regarding benefits (in terms of knowledge) be kept and continued public trust ensured. Time and again, scientific knowledge has been utilized to great benefit for humans, animals, and the environment. The HBA, as it currently stands, tends to turn this idea upside down and implies that research is of value only if the resulting findings bring about direct practical benefits, which science itself can neither provide nor guarantee. The road to hell is, as the saying goes, paved with good intentions. ABSTRACT: It is our concern that European Union Directive 2010/63/EU with its current project evaluation of animal research in the form of a harm–benefit analysis may lead to an erosion of the credibility of research. The HBA assesses whether the inflicted harm on animals is outweighed by potential prospective benefits. Recent literature on prospective benefit analysis prioritizes “societal benefits” that have a foreseeable, positive impact on humans, animals, or the environment over benefit in the form of knowledge. In this study, we will argue that whether practical benefits are realized is (a) impossible to predict and (b) exceeds the scope and responsibility of researchers. Furthermore, we believe that the emphasis on practical benefits has the drawback of driving researchers into speculation on the societal benefit of their research and, therefore, into promising too much, thereby leading to a loss of trust and credibility. Thus, the concepts of benefit and benefit assessment in the HBA require a re-evaluation in a spirit that embraces the value of knowledge in our society. The generation of scientific knowledge has been utilised to great benefit for humans, animals, and the environment. The HBA, as it currently stands, tends to turn this idea upside down and implies that research is of value only if the resulting findings bring about immediate societal benefit.